In-hospital clinical outcome in elderly patients with acute myocardial infarction treated with primary angioplasty

Italian Heart Journal

Volumn 4, Issue 3, 2003, Pages 193-198

  Tespili, Maurizio ^a   Guagliumi, Giulio ^a   Valsecchi, Orazio ^a   Musumeci, Giuseppe ^a   Vassileva, Angelina ^a   Saino, Antonio ^a   Scuri, Pier Mario ^a   Gavazzi, Antonello ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Aging; Angioplasty; Myocardial infarction; Primary

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BALLOON; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY REPERFUSION; CORONARY STENT; DEATH; DISEASE CLASSIFICATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; REGISTRATION; SEX DIFFERENCE; ST SEGMENT ELEVATION; STROKE; SURGICAL MORTALITY; SYMPTOMATOLOGY; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CREATINE KINASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRA-AORTIC BALLOON PUMPING; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE COMPLICATIONS; PREVALENCE; STENTS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 0038142686     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol 2001; 38: 736-41.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-60.
3. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
4. International Joint Efficacy Comparison of Thrombolytics. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995; 346: 329-36.
5. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118-23.
6. The Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. N Engl J Med 1997; 337: 1124-30.
7. Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation 1996; 94: 911-21.
8. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673-9.
9. Holmes DR Jr, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol 1999; 33: 412-9.
10. Stone GW, Grines CL, Browne KF, et al. Predictors of inhospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995; 25: 370-7.
11. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621-8.
12. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54.
13. Wilcox RG, von der Lippe G, Olsson CG, Skene AM. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988; 2: 525-30.
14. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled trial. Lancet 1988; 1: 545-9.
15. Anderson JL, Sorensen SG, Moreno FL, et al. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators. Circulation 1991; 83: 126-40.
16. Califf RM, Topol EJ, Stack RS, et al. Evaluation of combination tbrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction - phase 5 randomized trial. The TAMI Study Group. Circulation 1991; 83: 1543-56.
17. Wall TC, Califf RM, George BS, et al. Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group. J Am Coll Cardiol 1992; 19: 482-9.
18. Cannon CP, McCabe CH, Diver DJ, et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol 1994; 24: 1602-10.
19. DeGeare VS, Stone GW, Grines L, et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infaretion undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol 2000; 86: 30-4.
20. Sakai K, Nakagawa Y, Kimura T, et al. Comparison of results of coronary angioplasty for acute myocardial infarction in patients ≥ 75 years of age versus patients < 75 years of age. Am J Cardiol 2002; 89: 797-800.
21. Matetzky S, Sharir T, Noc M, et al. Primary angioplasty for acute myocardial infarction in octogenarians. Am J Cardiol 2001; 88: 680-3.
22. de Boer MJ, Ottervanger JP, van't Hof AWJ, Hoorntje JCA, Suryapranata H, Zijlstra F, for the Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction. A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002; 39: 1723-8.
23. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51.
24. Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 1998; 82: 1311-7.
25. Yang XS, Willems JL, Pardaens J, De Geest H. Acute myocardial infarction in the very elderly. A comparison with younger age groups. Acta Cardiol 1987; 42: 59-68.
26. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
27. Topol EJ, Califf RM. Thrombolytic therapy for elderly patients. N EngI J Med 1992; 327: 45-7.
28. Gurwitz JH, Goldberg RJ, Gore GM. Coronary thrombolysis for the elderly? JAMA 1991; 265: 1720-3.
29. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with acute myocardial infarction who are older than 75 years. Circulation 2000; 101: 2239-46.
30. Danchin N, Vaur L, Genes N, et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997; 30: 1598-605.
31. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1-14.
32. De Gregorio J, Kobayashi Y, Albiero R, et al. Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. J Am Coll Cardiol 1998; 32: 577-85.